Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...
A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer ...
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
News Medical on MSN11h
Chemical compound lights up treatment-resistant cancers on imaging scansResearchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.
MyChesCo on MSN16h
Promising New Radiopharmaceutical Shows Breakthrough Potential in Cancer TreatmentWEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has unveiled significant preclinical results for its ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical ...
GlobalData on MSN18h
GSK’s lung cancer therapy gains EMA PRIME designationGlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has gained priority medicines (PRIME) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback